China Pharma Holdings, Inc. (CPHI)
| Market Cap | 30.80M |
| Revenue (ttm) | 11.46M |
| Net Income (ttm) | -2.97M |
| Shares Out | 43.58M |
| EPS (ttm) | -0.07 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 11 |
| Last Price | $0.707 |
| Previous Close | $0.720 |
| Change ($) | -0.013 |
| Change (%) | -1.85% |
| Day's Open | 0.750 |
| Day's Range | 0.700 - 0.750 |
| Day's Volume | 518,085 |
| 52-Week Range | 0.320 - 1.630 |
HAIKOU, China, June 9, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced plans to launch...
HAIKOU, China, May 14, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced financial resul...
China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port
HAIKOU, China, April 19, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, commented on the policy state...
Shares of several penny stocks are on the rise today as Reddit investors continue to pick out the top ones to take a risk on. The post Top Penny Stocks Today: What to Know About BAYP, SEAC, UPC, CPHI, C...
HAIKOU CITY, China , March 26, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrate...
Face mask play China Pharma Holdings is trending higher today, and investors are noticing. Here is what you should know about CPHI stock.
China Pharma Holdings Inc. (CPHI) CEO Zhilin Li on Q4 2019 Results - Earnings Call Transcript
China Pharma's (CPHI) CEO Zhilin Li on Q2 2019 Results - Earnings Call Transcript
China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q1 2019 Results - Earnings Call Transcript
China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q4 2018 Results - Earnings Call Transcript
About CPHI
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of th... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | |
| CEO Zhilin Li | Employees 237 |
| Stock Exchange NYSEAMERICAN | Ticker Symbol CPHI |
Financial Performance
In 2020, CPHI's revenue was $10.87 million, a decrease of -0.53% compared to the previous year's $10.92 million. Losses were -$2.87 million, -86.15% less than in 2019.